The Tumor Suppressor PP2A as a Therapeutic Target for Eradication of TKI-resistant Ph+ Leukemic Stem Cells

Description

Host: Ross Levine, MD
Tea will be served at 4:15 pm.

Audience

This program is for the research community.

Date & Time(s)

Location

Memorial Sloan Kettering Cancer Center
Zuckerman Research Center
417 East 68th Street
Room ZRC 105
New York, NY 10065

Sponsor(s)

Human Oncology and Pathogenesis Program

Speaker(s)

Danilo Perrotti, MD, PhD
Assistant Professor
Molecular Virology, Immunnology, and Genetics
Ohio State University
Columbus, OH